Using 3D ultrasound for liver and kidney tumor procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of 3D ultrasound guidance during standard care ablation or biopsy procedures for liver and kidney tumors. The 3D ultrasound technology captures a series of 2D images that are then transformed into a 3D volume, allowing for enhanced visualization of the targeted area. Physicians will acquire images during the procedures, and these will be compared with pre- and post-procedure CT images to assess the accuracy of tumor removal or targeting. The study aims to improve diagnostic and intervention outcomes for patients undergoing these procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* • Patients who are scheduled for standard care liver or kidney ablation or biopsy

Exclusion Criteria:

* None

Where it's running

• Victoria Hospital
  London, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Aaron Fenster
• Email: afenster@uwo.ca
• Phone: 5199315777

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting Immunotherapy Response from Live Tumor Biopsies

  This project will try to see if analyzing live tumor biopsy samples kept in their 3D environment can predict whether people with advanced solid tumors will respond to immunotherapy.

  Recruiting at 7 sites Elephas · Fort Smith, Arkansas and 7 other locations · NCT07327489

• Virtual exercise program to preserve function and prevent disability during chemotherapy

  This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.

  Recruiting at 29 sites Alliance for Clinical Trials in Oncology · Dublin, California and 29 other locations · NCT07059884

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• Developing a markerless tracking method for real-time tumor motion measurement during radiation therapy

  This study is testing a new way to track tumor movement during radiation therapy without using markers, to see if it can help doctors target the treatment more accurately for cancer patients.

  Recruiting University of Sydney · Saint Leonards, New South Wales and 3 other locations · NCT05184790

• Microwave ablation for treating small kidney and liver tumors

  This study is testing whether microwave ablation can safely and effectively treat small kidney and liver tumors in patients while they continue their regular care.

  Recruiting IRCCS San Raffaele · Milan · NCT03981497

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.